Entry details

Matheu et al. (2004) "Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging." Genes Dev. 18(22):2736-2746 (PubMed)

Cited by (in linked databases)

  1. CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) GenAge: Human Ageing-Associated Genes